Pain management
Conditions
Interventions
A:Tegileridine for analgesic therapy after surgery
B:Sufentanil for analgesic therapy after surgery
Sponsors
Fujian Medical University Union Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)Patients who are scheduled to undergo open or laparoscopic radical gastrectomy for gastric cancer. (2) Age: 18 to 65 years old. (3) ASA classification I-III. (4) Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) There are contraindications for nerve block (such as infection at the puncture site). (2) There are communication barriers and they are unable to cooperate with the research. (3) Body mass index (BMI) 30 kg/m^2. (4) Preoperative examination indicated that the tumor had distant metastasis. (5) There is a history of chronic pain or chronic opioid use (daily opioid use for >= 3 months or morphine >= 60 mg/d and use for >= 1 month). (6) There are contraindications for the use of the relevant drugs in the research. (7) Participated in other clinical trials within the past three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SPID24;SPID48; | — |
Secondary
| Measure | Time frame |
|---|---|
| SPID;the time of the first postoperative remedial analgesia;Cumulative dosage and frequency of remedial analgesic drugs within 0 to 48 hours;Incidence of chronic pain; | — |
Countries
China
Contacts
Public ContactXianfeng Weng
Fujian Medical University Union Hospital
Outcome results
None listed